Heart failure. Heart failure
Conditions
Interventions
Intervention 1: Intervention Group: Patients with heart failure in the intervention group will first complete questionnaires assessing sleep quality and anxiety, and their physiological parameters, in
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Willingness to Participate in the Study Signing of Informed Consent Form Ability to speak and understand the Persian language Diagnosed heart failure (EF < 40%), as confirmed by the treating physician
Exclusion criteria
Exclusion criteria: Presence of conditions such as intellectual disability, mental or behavioral disorders, hearing impairment, or speech disorders Presence of a previously diagnosed psychiatric disorder and/or sleep disorder Use of complementary therapies prior to the study Presence of addiction to alcohol, illicit drugs, or sedative medications Use of sedative or anti-anxiety medications within the past 24 hours Presence of any contraindication at the pressure application site (e.g., wounds, skin diseases, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep Quality. Timepoint: Before the start of the study and on the second, third, and fourth days of hospitalization. Method of measurement: Pittsburgh Sleep Quality Index (PSQI).;Anxiety. Timepoint: Spielberger Anxiety Questionnaire. Method of measurement: Before, immediately after, and 30 minutes after the daily intervention.;Arterial oxygen saturation. Timepoint: Before, immediately after, and 30 minutes after the daily intervention. Method of measurement: Pulse oximetry.;Systolic blood pressure. Timepoint: Before, immediately after, and 30 minutes after the intervention. Method of measurement: Digital sphygmomanometer.;Diastolic blood pressure. Timepoint: Before, immediately after, and 30 minutes after the intervention. Method of measurement: Digital sphygmomanometer.;Heart rate. Timepoint: Before, immediately after, and 30 minutes after the intervention. Method of measurement: Pulse oximetry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Afshari
Hamedan University of Medical Sciences
Outcome results
None listed